Breaking News: CSLLY – Market Insights, Analysis & Latest Updates

CSLLY

Falling US flu vaccine rates hurt Australia's CSL profit growth

CSL's vaccine sales and profits decline due to falling U.S. immunization rates, raising public health concerns and affecting their financial outlook despite growth in their blood-plasma business.

investing.com • 11/02/2025 - 03:28 AM

CSLLY
GSK
SNY

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply

GSK, Sanofi, and CSL received $72 million from the U.S. government to boost bird flu vaccine production amid a recent outbreak affecting livestock and poultry.

investing.com • 04/10/2024 - 15:08 PM

CSLLY

CSL gets $121 million contract to increase US stockpile for bird flu vaccines to 40 million doses

CSL has secured a $121.4 million contract with HHS to produce 40 million bird flu vaccine doses, supporting U.S. pandemic preparedness amidst ongoing H5 avian influenza concerns.

investing.com • 25/09/2024 - 21:31 PM

Greed and Fear Index

Note: The data is for reference only.

Fear

Falling US flu vaccine rates hurt Australia's CSL profit growth

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply

CSL gets $121 million contract to increase US stockpile for bird flu vaccines to 40 million doses

Currency